Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah A Weiss

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
JCI Insight|February 23, 2023
Lenvatinib or anti-VEGF in combination with anti-PD-1 differentially augments antitumor activity in melanomaThuy T Tran, Jasmine Caulfield, Lin Zhang, et al.
Frontiers in Oncology|May 24, 2023
The role of imaging and sentinel lymph node biopsy in patients with T3b-T4b melanoma with clinically negative diseaseMarianna V Papageorge, Renee M Maina, Amber Loren O King, et al.
Frontiers in Oncology|March 30, 2022
Immune Checkpoint Inhibitor-Induced Hypophysitis and Patterns of Loss of Pituitary FunctionShlomit Jessel, Sarah A Weiss, Matthew Austin, et al.
BMJ Open Ophthalmology|January 20, 2022
Autoimmune retinopathy with associated anti-retinal antibodies as a potential immune-related adverse event associated with immunotherapy in patients with advanced cutaneous melanoma: case series and systematic reviewJacob S Heng, Jenna M Kim, D Kyle Jones, et al.
Diabetes|June 26, 2018
Collateral Damage: Insulin-Dependent Diabetes Induced With Checkpoint InhibitorsAngeliki M Stamatouli, Zoe Quandt, Ana Luisa Perdigoto, et al.
Cancer Immunology Research|February 13, 2026
Ex vivo expansion of melanoma tumor infiltrating lymphocytes leads to a dominant exhausted T cell population with lack of memory markersGianfilippo Coppola, Samuel Kerr, Pei-Chun Cha, et al.
Nature Immunology|May 14, 2024
The aged tumor microenvironment limits T cell control of cancerAlex C Y Chen, Sneha Jaiswal, Daniela Martinez, et al.
Nature Communications|April 12, 2019
A CRISPR-Cas9 delivery system for in vivo screening of genes in the immune systemMartin W LaFleur, Thao H Nguyen, Matthew A Coxe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2017
Tumor Microvessel Density as a Prognostic Marker in High-Risk Renal Cell Carcinoma Patients Treated on ECOG-ACRIN E2805Lucia B Jilaveanu, Maneka Puligandla, Sarah A Weiss, et al.
Cancer|November 27, 2019
PLEKHA5 regulates tumor growth in metastatic melanomaHongyi Zhang, Huifang Zhu, Gang Deng, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
JCI Insight|February 23, 2023
Lenvatinib or anti-VEGF in combination with anti-PD-1 differentially augments antitumor activity in melanomaThuy T Tran, Jasmine Caulfield, Lin Zhang, et al.
Frontiers in Oncology|May 24, 2023
The role of imaging and sentinel lymph node biopsy in patients with T3b-T4b melanoma with clinically negative diseaseMarianna V Papageorge, Renee M Maina, Amber Loren O King, et al.
Frontiers in Oncology|March 30, 2022
Immune Checkpoint Inhibitor-Induced Hypophysitis and Patterns of Loss of Pituitary FunctionShlomit Jessel, Sarah A Weiss, Matthew Austin, et al.
BMJ Open Ophthalmology|January 20, 2022
Autoimmune retinopathy with associated anti-retinal antibodies as a potential immune-related adverse event associated with immunotherapy in patients with advanced cutaneous melanoma: case series and systematic reviewJacob S Heng, Jenna M Kim, D Kyle Jones, et al.
Diabetes|June 26, 2018
Collateral Damage: Insulin-Dependent Diabetes Induced With Checkpoint InhibitorsAngeliki M Stamatouli, Zoe Quandt, Ana Luisa Perdigoto, et al.
Cancer Immunology Research|February 13, 2026
Ex vivo expansion of melanoma tumor infiltrating lymphocytes leads to a dominant exhausted T cell population with lack of memory markersGianfilippo Coppola, Samuel Kerr, Pei-Chun Cha, et al.
Nature Immunology|May 14, 2024
The aged tumor microenvironment limits T cell control of cancerAlex C Y Chen, Sneha Jaiswal, Daniela Martinez, et al.
Nature Communications|April 12, 2019
A CRISPR-Cas9 delivery system for in vivo screening of genes in the immune systemMartin W LaFleur, Thao H Nguyen, Matthew A Coxe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2017
Tumor Microvessel Density as a Prognostic Marker in High-Risk Renal Cell Carcinoma Patients Treated on ECOG-ACRIN E2805Lucia B Jilaveanu, Maneka Puligandla, Sarah A Weiss, et al.
Cancer|November 27, 2019
PLEKHA5 regulates tumor growth in metastatic melanomaHongyi Zhang, Huifang Zhu, Gang Deng, et al.
Pageof 5